Physician

Gergana Patrova Popova-Orahovats, MD

According to 2025 Medicare claims, Gergana Popova-Orahovats, MD (NPI: 1467435420) practices family practice in the Cheyenne, WY market, with the plurality of this provider's patient population coming from Laramie, WY. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 82009-4800. Popova-Orahovats is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Popova-Orahovats' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,028 traditional Medicare patients, billed 10,815 HCPCS/CPT codes, and received $296,253 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 12,929 prescription claims across 793 beneficiaries totaling $1,059,924 in drug costs, led by Eliquis (Apixaban). DME data shows 1,622 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $535,337 to $1,059,924. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$168K$335K2015 Medicare payment: $290,370 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $249,735 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $202,572 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $270,094 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $281,799 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $295,599 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $335,158 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $281,183 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $288,328 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $296,253 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0079,277$290,370
20161,0438,836$249,735
20171,2568,076$202,572
20181,15310,058$270,094
20191,17710,766$281,799
20201,22811,588$295,599
20211,42711,641$335,158
20221,40410,799$281,183
20231,21310,265$288,328
20241,02810,815$296,253

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$558K$1.1M2015 Drug cost: $535,337 (USD; Tot_Drug_Cst)2016 Drug cost: $556,648 (USD; Tot_Drug_Cst)2017 Drug cost: $576,401 (USD; Tot_Drug_Cst)2018 Drug cost: $608,239 (USD; Tot_Drug_Cst)2019 Drug cost: $639,534 (USD; Tot_Drug_Cst)2020 Drug cost: $765,203 (USD; Tot_Drug_Cst)2021 Drug cost: $905,046 (USD; Tot_Drug_Cst)2022 Drug cost: $1,070,407 (USD; Tot_Drug_Cst)2023 Drug cost: $1,116,241 (USD; Tot_Drug_Cst)2024 Drug cost: $1,059,924 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155877,583$535,337
20165617,875$556,648
20175398,068$576,401
20185618,347$608,239
20195658,901$639,534
202060910,018$765,203
202166510,751$905,046
202279611,818$1,070,407
202373611,741$1,116,241
202479312,929$1,059,924

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$61K$122K2015 Medicare payment: $122,016 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $71,094 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $36,320 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $52,472 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $71,815 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $105,464 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $110,826 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $95,821 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $94,787 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $79,525 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20153251,586$122,016
20163141,508$71,094
20172691,102$36,320
20183481,320$52,472
20193581,511$71,815
20204481,925$105,464
20214951,912$110,826
20224201,771$95,821
20233741,649$94,787
20243901,622$79,525

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit455455$127
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more495706$57
80053Blood test, comprehensive group of blood chemicals494605$10
36415Insertion of needle into vein for collection of blood sample7321,117$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count449559$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban1479,543$183,619
MounjaroTirzepatide602,100$78,765
TrulicityDulaglutide562,212$72,000
JardianceEmpagliflozin563,617$69,082
OzempicSemaglutide502,282$66,763

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY52455$31,210
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R30$8,615
A7031Face mask interface, replacement for full face mask, eachN2059$5,504
A7030Full face mask used with positive airway pressure device, eachN1956$4,885
E1392Portable oxygen concentrator, rentalY1191$3,193

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Gergana Patrova Popova-Orahovats, MD?

Tedicare shows public-source Medicare data for Gergana Patrova Popova-Orahovats, MD (NPI 1467435420), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gergana Patrova Popova-Orahovats, MD have ACO affiliation data?

Gergana Patrova Popova-Orahovats, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Gergana Patrova Popova-Orahovats, MD?

Gergana Patrova Popova-Orahovats, MD is linked to POUDRE VALLEY MEDICAL GROUP, LLC (billing NPI 1366763260) in the available physician profile data.

Does Gergana Patrova Popova-Orahovats, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.